ASSOCIATIONS BETWEEN DIABETES MELLITUS AND OUTCOMES WITH THE COMBO BIO-ENGINEERED STENT: FROM THE MASCOT POST-MARKETING REGISTRY

ASSOCIATIONS BETWEEN DIABETES MELLITUS AND OUTCOMES WITH THE COMBO BIO-ENGINEERED STENT: FROM THE MASCOT POST-MARKETING REGISTRY

Patients were eligible if Combo stent implantation was attempted, and received dual antiplatelet therapy (DAPT) per local guidelines. Compared to non-DM patients, DM patients were older, female, non-white, with higher body mass index and greater prevalence of comorbidities- renal disease, polyvascul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A1443-A1443
Hauptverfasser: Chandrasekhar, Jaya, Colombo, Antonio, Aquino, Melissa, Ong, Tiong Kiam, Ge, Zhen, Farhan, Serdar, Lee, Michael Kang Yin, Iniguez, Andres, Joyce, Lauren, Snyder, Clayton, Sartori, Samantha, Baber, Usman, Morrell, Debbie, Elmore, Francesca, Rowland, Stephen, Mehran, Roxana
Format: Artikel
Sprache:eng
Schlagworte:
Bioengineering
Cardiology
Clinical outcomes
Diabetes
Diabetes mellitus
Implants
Mascots
Stents
Surgical implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Patients were eligible if Combo stent implantation was attempted, and received dual antiplatelet therapy (DAPT) per local guidelines. Compared to non-DM patients, DM patients were older, female, non-white, with higher body mass index and greater prevalence of comorbidities- renal disease, polyvascular disease, prior revascularization and stable angina or non-ST segment elevation MI presentation.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(18)31984-3